510(k) · Cleared
Recalled · Class I · 2020NC Trek RX Coronary Dilatation Catheter
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Abbott Vascular-Cardiac Therapies · LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous
Cleared on Feb 11, 2011 after a 24-day review. The FDA summary names its predicate without a number. 1 of the 7 devices in its family, counting itself, has a Class I recall. 6 later devices descend from it. It has been recalled 17 times, including 17 Class I recalls.
- Decided
- Feb 11, 2011
- Review
- 24 days
- Class
- Class II
- Product code
- LOX
- Recalls
- 17 (17 Class I)
- Predicates
- 0
6 later devices descend from it, 3 citing it directly. 1 of the 7 devices in this family, counting this one, has a Class I recall.
- This deviceK110134 NC Trek RX Coronary Dilatation CatheterAbbott Vascular-Cardiac Therapies · 2011
- Descendant · cites it directly · 2 of its ownK180040 NC TREK™ RX Coronary Dilatation Catheter; NC TREK™ OTW Coronary…Abbott Vascular · 2018
- Descendant · cites it directly · 1 of its ownK162434 NC Gallant PTCA CatheterMedinol, Ltd. · 2017
- Descendant · 2 generations on · 0 of its ownK252116 Firefighter™ Pro PTCA Balloon CatheterShanghai MicroPort Medical (Group) Co., Ltd. · 2026
- Descendant · 2 generations on · 0 of its ownK220634 NC TREK NEO Coronary Dilatation CatheterAbbott Vascular · 2022
- Descendant · 2 generations on · 0 of its ownK173581 Gallant PTCA Dilatation CatheterMedinol, Ltd. · 2018
Showing 5 of 6 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 6 · See all- K180040NC TREK™ RX Coronary Dilatation Catheter; NC TREK™ OTW Coronary Dilatation Catheter…Abbott Vascular · 2018 · cites it directly2descendants
- K162434NC Gallant PTCA CatheterMedinol, Ltd. · 2017 · cites it directly1descendant
- K252116Firefighter™ Pro PTCA Balloon CatheterShanghai MicroPort Medical (Group) Co., Ltd. · 2026 · 2 generations on0descendants
- K220634NC TREK NEO Coronary Dilatation CatheterAbbott Vascular · 2022 · 2 generations on0descendants
- K173581Gallant PTCA Dilatation CatheterMedinol, Ltd. · 2018 · 2 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K110134 | NC Trek RX Coronary Dilatation Catheter | Abbott Vascular-Cardiac Therapies | 2011 | — |
| +1 | K180040 | NC TREK™ RX Coronary Dilatation Catheter; NC TREK™ OTW Coronary Dilatation… | Abbott Vascular | 2018 | — |
| +1 | K162434 | NC Gallant PTCA Catheter | Medinol, Ltd. | 2017 | — |
| +2 | K252116 | Firefighter™ Pro PTCA Balloon Catheter | Shanghai MicroPort Medical (Group) Co., Ltd. | 2026 | — |
| +2 | K220634 | NC TREK NEO Coronary Dilatation Catheter | Abbott Vascular | 2022 | — |
| +2 | K173581 | Gallant PTCA Dilatation Catheter | Medinol, Ltd. | 2018 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2015 | 1 | 0 |
| 2017 | 1 | 0 |
| 2018 | 2 | 0 |
| 2022 | 1 | 0 |
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LOX device
- #1 K254022 FLASH Flex™ Aorto-Ostial Angioplasty Systemscore 12.3 · 5 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | — | NC TREK RN Coronary Dilatation Catheter Named without a submission number |
What descends from it? (6)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (1 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Jan 29, 2020 | Class I | Z-1136-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1131-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1130-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1133-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1135-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1128-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1134-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1143-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1129-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1142-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1140-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1144-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1132-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1138-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1139-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1141-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
| Jan 29, 2020 | Class I | Z-1137-2020 | Process change control | Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon. |
The 5 latest of 17 recalls; the web page lists all.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K180040 (Abbott Vascular, 2018) has gone furthest, with 2 descendants of its own.
How does its category compare?
All LOX devicesLOX Catheters, Transluminal Coronary Angioplasty, Percutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.
FDA decisions per year · LOX
4in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · LOX
241in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LOX
4in 2019
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LOX
1,890in 2025
MAUDE reports naming product code LOX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 19 | — | 1 | 1,053 |
| 2008 | 22 | — | 80 | 1,063 |
| 2009 | 28 | — | 0 | 1,353 |
| 2010 | 32 | — | 0 | 1,392 |
| 2011 | 9 | 103 | 0 | 2,090 |
| 2012 | 10 | 120 | 0 | 2,092 |
| 2013 | 6 | 123 | 0 | 2,436 |
| 2014 | 6 | 166 | 0 | 2,316 |
| 2015 | 4 | 119 | 0 | 2,060 |
| 2016 | 9 | 116 | 0 | 2,578 |
| 2017 | 6 | 113 | 0 | 2,753 |
| 2018 | 7 | 80 | 0 | 2,225 |
| 2019 | 1 | — | 4 | 2,102 |
| 2020 | 1 | — | 0 | 1,974 |
| 2021 | 6 | 167 | 0 | 1,738 |
| 2022 | 5 | 121 | 0 | 1,816 |
| 2023 | 4 | 138 | 0 | 1,720 |
| 2024 | 4 | 241 | 0 | 1,804 |
| 2025 | 0 | — | 0 | 1,890 |
| 2026 | 6 | 156 | 0 | — |
What is it indicated for?
The NC TREKTM RX Coronary Dilatatoin Catheter is indicated for:
a) balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenrosis for the purpose of improving myocardial perfusion;
b) balloon dilatation of a coronary artery occlusion for the purpose of restoring coronary flow in patients with ST-segment elevation myocardial infarction;
c) balloon dilatation of a stent after implantation (balloon models 2.0 mm -5.0Omm only).
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K110134 · printed Nov 6, 2026
Cite this page
510(k) Report. “K110134: NC Trek RX Coronary Dilatation Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K110134
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026